2024-25 SELICB-LGT - CV4

Opportunity overview

Additional funding from NHS SEL ICB to be added to the Contract Value which brings the revised annual total Contract Value from £675,230,000 to £720,141,000. The lifetime value is now £3,600,705,000. This modification is effective from 17th June 2025. This award was made under what the relevant authority considered to be urgent circumstances. The decision to modify this Contract was approved by the SEL ICB GSTT Contract Management Board, and the Contract signed by SEL ICB Chief Executive Officer. No conflicts of interest were declared, noting SEL ICB's 'Standards of Business Conduct' policy is in line with arrangements outlined within the SEL ICB constitution to support the integrity of decision-making processes and help staff manage conflicts of interest risks effectively. This is a Provider Selection Regime (PSR) contract modification notice, under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. This contract has now been formally modified.

Awarded to

Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.

Classification

• CPV85110000 — Hospital and related services

Lots

• This contract award was originally made following Direct Award Process A (The Health Care Services (Provider Selection Regime) Regulations 2023, Regulation 7). The provider is a NHS Foundation Trust, providing acute health care services including, but not limited to, Commissioner Requested Services (CRS) / Essential Services and specialised services. The provider is the only provider capable of delivering the services due to the nature of those health care services. The contract will start on 01/04/2024 and end 31/03/2027, if the optional extension if utilised the contract end date will be 31/03/2029.Value not stated